Observational studyProstate cancer and prostatic diseases2026

DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysis.

Evan Y Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.